PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 24, 2020Scientific Reports36 citationsOpen Access

Cryptogenic stroke and atrial fibrillation in a real-world population: the role of insertable cardiac monitors

MAMaria Vittoria De AngelisVSVincenzo Di StefanoRFRaffaella Franciotti

Key Result

Continuous monitoring with insertable cardiac monitors detected atrial fibrillation in 41% of patients with cryptogenic stroke over a 3-year follow-up period.

Study Design

Type

Observational (n=58)

Blinding

Open-label

Multicenter

No

Structured PICO

Does continuous monitoring with an insertable cardiac monitor improve detection of atrial fibrillation in patients with cryptogenic stroke?

P
Population
58 patients with cryptogenic stroke admitted to a Stroke Unit, mean age 68.1 years, 67% male.
I
Intervention
Insertable cardiac monitor (ICM) for continuous monitoring up to 3 years.
O
Outcome
Detection of atrial fibrillation (AF) episodes of at least 120 seconds.surrogate

Insertable cardiac monitors detected atrial fibrillation in 41% of real-world patients with cryptogenic stroke, supporting their routine use in this population.

Limitations

  • Device requires at least 2 minutes of AF to be detected
  • Small sample size
  • Open label prospective study without comparison with other forms of monitoring
  • Possible delay in device implantation

Abstract

The incidence of atrial fibrillation (AF) in cryptogenic stroke (CS) patients has been studied in carefully controlled clinical trials, but real-world data are limited. We investigated the incidence of AF in clinical practice among CS patients with an insertable cardiac monitor (ICM) placed for AF detection. Patients with CS admitted to our Stroke Unit were included in the study; they received an ICM and were monitored for up to 3 years for AF detection. All detected AF episodes of at least 120 sec were considered. From March 2016 to March 2019, 58 patients (mean age 68.1 ± 9.3 years, 67% male) received an ICM to detect AF after a CS. No patients were lost to follow-up. AF was detected in 24 patients (41%, AF group mean age 70.8 ± 9.4 years, 62% male) after a mean time of 6 months from ICM (ranging from 2 days to 2 years) and 8 months after CS (ranging from 1 month to 2 years). In these AF patients, anticoagulant treatment was prescribed and nobody had a further stroke. In conclusion, AF episodes were detected via continuous monitoring with ICMs in 41% of implanted CS patients. AF in CS patients is asymptomatic and difficult to diagnose by strategies based on intermittent short-term recordings. Therefore, we suggest that ICMs should be part of daily practice in the evaluation of CS patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Angelis et al. (2020) conducted an observational in Cryptogenic stroke (n=58). Insertable cardiac monitor (ICM) was evaluated on Detection of atrial fibrillation (AF). Continuous monitoring with insertable cardiac monitors detected atrial fibrillation in 41% of patients with cryptogenic stroke over a 3-year follow-up period.

synapsesocial.com/papers/6a0f2bb94994b59e774268c6https://doi.org/10.1038/s41598-020-60180-6
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.1993 · 12,428 citations
  2. 22016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016 · 405 citations
  3. 3Occult Atrial Fibrillation in Cryptogenic Stroke2013 · 180 citations
  4. 4Insertable Cardiac Event Recorder in Detection of Atrial Fibrillation After Cryptogenic Stroke2013 · 100 citations
  5. 5Evaluating the Atrial Myopathy Underlying Atrial Fibrillation2015 · 245 citations